ArticleCell death & disease2026

Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy.

Nikita Gorainow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.